NCT07600593

Brief Summary

The goal of this study is to develop a postpartum depression (PND) Risk index using the UK Biobank dataset, and to validate the risk index in Hong Kong postpartum women. Participating Hong Kong postpartum women will wear an actigraphy (GENEActive) for 14 consecutive days.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
19mo left

Started Jul 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2028

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

12 months

First QC Date

May 6, 2026

Last Update Submit

May 13, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Postpartum depressive symptoms (PND)

    PND refers to a mood disorder that affects individuals during pregnancy or within 1 year after childbirth. PND will be measured by the Edinburgh Postnatal Depression Scale (EPDS). The EPDS score ranges between 0 and 30, with higher score indicating worse PND symptoms.

    2 weeks and 6 weeks postpartum

  • Subjective sleep quality

    Subjective sleep quality will be measured both subjectively by the Pittsburgh Sleep Quality Index (PSQI). The PSQI score ranges between 0 and 21, with a higher score indicating worse subjective sleep quality.

    The PSQI will be reported once at 6 weeks postpartum.

  • Objective sleep efficiency

    Objective sleep efficiency (SE) will be measured by the accelerometer (GENEActiv). The unit for SE is percentage, and the mathematical bounds are 0% (minimum) to 100% (maximum). However, in human populations, healthy adults typically score between 85% and 90%. A higher percentage indicates a higher SE.

    Objective SE will be measured at 6 weeks postpartum for 14 consecutive days.

Secondary Outcomes (1)

  • Anxiety

    The STAI scale will be reported at 6 weeks postpartum

Study Arms (1)

Postpartum women

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female will be eligible to participate this study.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Postpartum mothers who gave birth within 6 months and reside in Hong Kong

You may qualify if:

  • Mothers who are at least 18 years of age and are within 6 months of giving birth.
  • Participants must be capable of reading Traditional Chinese, Mandarin, or English, to ensure they can provide informed consent and complete the required study documentation.

You may not qualify if:

  • Individuals with specific conditions that might interfere with the measurement of sleep patterns related to mood will be excluded. This includes mothers diagnosed with sleep apnea or those who use CPAP machines.
  • To reduce physiological noise in the data, women working permanent night shifts or those with severe medical complications, such as pre-eclampsia requiring ongoing medication, will also be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

May 6, 2026

First Posted

May 20, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

January 31, 2028

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

To comply with the IRB for this study, the data will not be shared with other researchers. All collected data will be stored securely for 5 years following study completion, in accordance with institutional research data management policies. Access to the Qualtrics survey responses will be strictly limited to the principal investigator, co-investigators and research assistants. Data will be stored in password-protected files on encrypted servers, and all identifying information will be removed during data analysis and reporting. After the 5-year retention period, all data will be permanently deleted by overriding each file.